Hosted on Acast. See acast.com/privacy for more information.
Hosted on Acast. See acast.com/privacy for more information.
Hosted on Acast. See acast.com/privacy for more information.
Hosted on Acast. See acast.com/privacy for more information.
In this podcast, Chiara De Biase and Jean Marco highlight three key reasons for Charles Dotter's failure to spread his method widely in the USA. Firstly, his position as a radiologist, not a vascular surgeon; secondly, his aggressive presentation of the technique, coupled with limited patient data; and lastly, his unconventional approach to developing tools and the lack of clear objectives.
Stay tuned to discover how Dotter's method made its way to Europe in the next episode.
Hosted on Acast. See acast.com/privacy for more information.
In this first episode, Chiara De Biase and Jean Marco discuss Dotter's groundbreaking contributions, including the first interventional transluminal angioplasty in 1964, which revolutionized vascular medicine. Despite Dotter's visionary work, his name was nearly forgotten.
Why was Dotter's disruptive innovation initially rejected? Stay tuned to uncover more about Dotter's legacy and the evolution of interventional medicine.
Hosted on Acast. See acast.com/privacy for more information.